| Name | GNE-955 |
|---|---|
| Synonyms |
GNE955,GNE
(3S)-1-[3-Methoxy-6-[6-(6-methylpyrazin-2-yl)pyrazolo[4,3-c]pyridin-1-yl]pyridin-2-yl]piperidin-3-amine 3-Piperidinamine, 1-[3-methoxy-6-[6-(6-methyl-2-pyrazinyl)-1H-pyrazolo[4,3-c]pyridin-1-yl]-2-pyridinyl]-, (3S) GNE-955( 5-Azaindazole) |
| Description | GNE-955 is a potent pan Pim kinase inhibitor with Kis of 18, 110, 8 nM for Pim1, Pim2, Pim3, respectively. |
|---|---|
| Related Catalog | |
| Target |
PIM1:18 nM (Ki) PIM2:110 nM (Ki) PIM3:8 nM (Ki) |
| In Vitro | MM.1S myeloma cell line treated with a dose range of GNE-955 reveals a constellation of PIM downstream signaling events consistent with inhibition of Pim kinases[1]. |
| In Vivo | GNE-955 has excellent bioavailability in rat. Rat clearance of GNE-955 is moderate at 34 mL /min/kg with good oral exposure[1]. |
| References |
| Molecular Formula | C22H24N8O |
|---|---|
| Molecular Weight | 416.5 |
| Exact Mass | 416.20730742 |